-Yasuhiro Terasaki Researcher Activity Profile

Research Author Detailed Information 

Yasuhiro Terasaki Publication Rate By Year

Yasuhiro Terasaki has published 2 paper(s) in 2006, 11 paper(s) in 2007, 1 paper(s) in 2008, for a total of 14 research publications in total.

Yasuhiro Y Terasaki Author Information

LAST NAME: terasaki

FIRST NAME: Yasuhiro

INITIALS: y

AFFILIATION:

Papers

Yasuhiro Terasaki's Publication Record

1. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis. Year Published: 2006
Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan.
2. Detection of guinea pig macrophages by a new CD68 monoclonal antibody, PM-1K. Year Published: 2006
Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan, takeya@kaiju.medic.kumamoto-u.ac.jp.
3. Rho-kinase activation in endothelial cells contributes to expansion of infarction after focal cerebral ischemia. Year Published: 2007
Stroke Division, Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. yagita@medone.med.osaka-u.ac.jp
4. Allergic inflammatory reaction is involved in necrosis of human pulmonary dirofilariasis. Year Published: 2007
Section of Pathology, Saitama Cardiovascular and Respiratory Centre, Saitama, Japan.
5. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models. Year Published: 2007
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd, 1188 Shimotogari, Sunto-gun, Nagaizumi-cho, Shizuoka, 4118731, Japan, hiroyuki.ishida@kyowa.co.jp.
6. Postischemic administration of HMG CoA reductase inhibitor inhibits infarct expansion after transient middle cerebral artery occlusion. Year Published: 2007
Osaka Neurological Institute, Toyonaka, Japan.
7. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia] Year Published: 2007
Division of Internal Medicine, Toyama City Hospital.
8. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia] Year Published: 2007
Division of Internal Medicine, Toyama City Hospital.
9. Rho-kinase activation in endothelial cells contributes to expansion of infarction after focal cerebral ischemia. Year Published: 2007
Stroke Division, Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. yagita@medone.med.osaka-u.ac.jp
10. Allergic inflammatory reaction is involved in necrosis of human pulmonary dirofilariasis. Year Published: 2007
Section of Pathology, Saitama Cardiovascular and Respiratory Centre, Saitama, Japan.
11. Postischemic administration of HMG CoA reductase inhibitor inhibits infarct expansion after transient middle cerebral artery occlusion. Year Published: 2007
Osaka Neurological Institute, Toyonaka, Japan.
12. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models. Year Published: 2007
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd, 1188 Shimotogari, Sunto-gun, Nagaizumi-cho, Shizuoka 4118731, Japan. hiroyuki.ishida@kyowa.co.jp
13. Postischemic administration of HMG CoA reductase inhibitor inhibits infarct expansion after transient middle cerebral artery occlusion. Year Published: 2007
Osaka Neurological Institute, Toyonaka, Japan.
14. [Primary mucosa-associated lymphoid tissue lymphoma of the urinary bladder successfully treated by radiotherapy and rituximab] Year Published: 2008
Division of Internal Medicine, Toyama City Hospital.